<DOC>
	<DOCNO>NCT02246582</DOCNO>
	<brief_summary>The purpose study demonstrate performance Enlite 3 Sensor 168 hour ( 7 day ) insert abdomen use Guardian Mobile App 640G Pump subject age 14-75 year type 1 type 2 diabetes .</brief_summary>
	<brief_title>Adult Accuracy Study Enlite 3 Glucose Sensor</brief_title>
	<detailed_description>This study multi-center , randomize , in-clinic trial aim demonstrate performance Enlite 3 Sensor 168 hour ( 7 day ) insert abdomen use Guardian Mobile App 640G Pump subject age 14-75 year type 1 type 2 diabetes least one year . Subjects randomize either Group A Group B . The group assign determine subject participate in-clinic YSI frequent sample test ( FST ) . For example Day 1 : Group A begin FST 30 minute Enlite 3 Sensor Insertion . Group B begin FST 14 hour Enlite 3 Sensor Insertion .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>1 . Subject 1475 year age time screen 2 . A clinical diagnosis type 1 type 2 diabetes minimum 12 month duration determine via medical record source documentation individual qualify make medical diagnosis 3 . Adequate venous access assess investigator appropriate staff 4 . Subjects participate high low glucose challenge must establish insulin carbohydrate ratio ( ) insulin sensitivity ratio . ( The term `` establish '' refers ratio previously define test prior screen visit ) . Subjects without establish ratio may participate observation . 1 . Subject tolerate tape adhesive area Enlite 3 Sensor placement assess qualified individual 2 . Subject unresolved adverse skin condition area Enlite 3 Sensor device placement ( e.g . psoriasis , rash , Staphylococcus infection ) 3 . Subject actively participate investigational study ( drug device ) last 2 week 4 . Subject female positive pregnancy screen test 5 . Females child bear age sexually active exclude use form contraception deem reliable investigator 6 . Subject female plan become pregnant course study 7 . Subject hypoglycemic seizure within past 6 month 8 . Subject hypoglycemia result loss consciousness within past 6 month prior screen visit 9 . Subject episode diabetic ketoacidosis ( DKA ) within past 6 month prior screen visit 10 . Subject history seizure disorder 11 . Subject central nervous system cardiac disorder result syncope 12 . Subject history myocardial infarction , unstable angina , coronary artery bypass surgery , coronary artery stenting , transient ischemic attack ( TIA ) , cerebrovascular accident ( CVA ) , angina , congestive heart failure , ventricular rhythm disturbance thromboembolic disease 13 . Subject hematocrit ( Hct ) low normal reference range 14 . Subject history adrenal insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Type 1 Diabetes</keyword>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Enlite 3</keyword>
</DOC>